Oxaliplatin combined with infusional 5-fluorouracil and concomitant radiotherapy in inoperable and metastatic rectal cancer: a phase I trial

The aim of this study was to define the recommended dose of oxaliplatin when combined with infusional 5-fluorouracil (5-FU) and concurrent pelvic radiotherapy. Eligible patients had inoperable rectal cancer, or symptomatic primary rectal cancer with metastasis. Oxaliplatin was given on day 1 of week...

Descripción completa

Detalles Bibliográficos
Autores principales: Loi, S, Ngan, S Y K, Hicks, R J, Mukesh, B, Mitchell, P, Michael, M, Zalcberg, J, Leong, T, Lim-Joon, D, Mackay, J, Rischin, D
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2005
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361867/
https://www.ncbi.nlm.nih.gov/pubmed/15700033
http://dx.doi.org/10.1038/sj.bjc.6602413

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361867/
https://www.ncbi.nlm.nih.gov/pubmed/15700033
http://dx.doi.org/10.1038/sj.bjc.6602413

Ejemplares similares